THOMAS F. ACKERMAN - Corporate Board Profile

ARTIVION, INC.

Filing Date	Source Excerpt
2015-04-20	Thomas F. Ackerman has served as a Director of CryoLife since December 2003. ... The Board has determined that Mr. Ackerman should serve as a Director of CryoLife because of his expertise in accounting and financial reporting, particularly in the biotechnology industry. ... Audit Committee: Mr. Morgan, Chairman, Mr. Ackerman, and Mr. Bevevino, each of whom served on the Audit Committee for all of 2014. ... Fiscal 2014 Director Compensation: Thomas F. Ackerman Fees Earned or Paid in Cash $47,500, Stock Awards $99,500, Total $147,000.
2016-04-21	Thomas F. Ackerman has served as a Director of CryoLife since December 2003. The Board of Directors has determined that Mr. Ackerman should serve as a Director of CryoLife because of his expertise in accounting and financial reporting, particularly in the biotechnology industry. During 2015, he served on the Audit Committee. Fiscal 2015 Director Compensation for Thomas F. Ackerman was $147,293.
2017-03-29	Thomas F. Ackerman has served as a director of CryoLife since December 2003. The Board of Directors has determined that Mr. Ackerman should serve as a director of CryoLife because of his expertise in accounting and financial reporting, particularly in the biotechnology industry. During 2016, the Board of Directors had four standing committees: the Audit Committee, the Compensation Committee, the Corporate Governance Committee and the Compliance Committee. The following table lists the members of each of the standing committees as of the date of this Proxy Statement: Thomas F. Ackerman - Audit Committee, Compensation Committee. The following table provides compensation information for the one-year period ended December 31, 2016, for each person who was a member of our Board of Directors in 2016, other than J. Patrick Mackin: Thomas F. Ackerman - $151,099.
2018-04-03	Thomas F. Ackerman has served as a director of CryoLife since December 2003. ... The Board of Directors has determined that Mr. Ackerman should serve as a director of CryoLife because of his expertise in accounting and financial reporting, particularly in the biotechnology industry. ... During 2017, the Board of Directors had four standing committees: the Audit Committee, the Compensation Committee, the Corporate Governance Committee, and the Compliance Committee. ... The following table lists the members of each of the standing committees as of the date of this Proxy Statement: Thomas F. Ackerman: Audit Committee, Compensation Committee. ... Fiscal 2017 Director Compensation: Thomas F. Ackerman total compensation $148,550.
2019-03-26	Thomas F. Ackerman has served as a director of CryoLife since December 2003. ... The Board of Directors has determined that Mr. Ackerman should serve as a director of CryoLife because of his expertise in accounting and financial reporting, particularly in the biotechnology industry. ... During 2018, the Board of Directors had four standing committees: the Audit Committee, the Compensation Committee, the Corporate Governance Committee, and the Compliance Committee. ... The following table lists the members of each of the standing committees as of the date of this Proxy Statement: Thomas F. Ackerman Audit Committee, Compensation Committee. ... Fiscal 2018 Director Compensation: Thomas F. Ackerman Fees Earned or Paid in Cash $58,333, Stock Awards $124,994, Total $183,327.
2020-03-31	Thomas F. Ackerman has served as a director of CryoLife since December 2003. ... The Board of Directors has determined that Mr. Ackerman should serve as a director of CryoLife because of his expertise in accounting and financial reporting, particularly in the biotechnology industry. ... During 2019, the Board of Directors had four standing committees: the Audit Committee, the Compensation Committee, the Corporate Governance Committee, and the Compliance Committee. ... Thomas F. Ackerman: Audit Committee, Compensation Committee. ... Fiscal 2019 Director Compensation: Thomas F. Ackerman: $187,515.
2021-03-30	Thomas F. Ackerman has served as a director of CryoLife since December 2003... The following table provides compensation information for the one-year period ended December 31, 2020, for each person who was a member of our Board of Directors in 2020, other than J. Patrick Mackin: Thomas F. Ackerman Retainers Earned or Paid in Cash 32,500 Stock Awards - Granted in lieu of Suspended Cash Retainers 32,927 Annual Stock Awards 130,001 Total 195,428
2021-10-07	Thomas F. Ackerman Director
2022-04-04	Thomas F. Ackerman has served as a director of Artivion since December 2003. The Board of Directors has determined that Mr. Ackerman should serve as a director of Artivion because of his expertise in accounting and financial reporting, particularly in the biotechnology industry. He serves as Chair of the Audit Committee. Fiscal 2021 Director Compensation: Thomas F. Ackerman received $75,000 in retainers and $129,992 in annual stock awards, totaling $204,992.
2023-04-03	Thomas F. Ackerman has served as a director of Artivion since December 2003. The Audit Committee currently consists of three non-employee directors: Mr. Ackerman, Chair, Mr. Bevevino, and Mr. Burbank. Mr. Ackerman and Mr. Bevevino served on the Audit Committee for all of 2022. Mr. Ackerman began serving on the Compliance Committee in May 2022. Fiscal 2022 Director Compensation: Thomas F. Ackerman Retainers Earned or Paid in Cash $79,096, Annual Stock Awards $150,000, Total $229,096.
2024-04-01	Thomas F. Ackerman has served as a director of Artivion since December 2003. The Board of Directors has determined that Mr. Ackerman should serve as a director of Artivion because of his expertise in accounting and financial reporting, particularly in the biotechnology industry. He serves as Chair of the Audit Committee and is a member of the Compliance Committee. Fiscal 2023 Director Compensation: $230,004.
2025-04-01	Thomas F. Ackerman has served as a director of Artivion since December 2003. The Board of Directors has determined that Mr. Ackerman should serve as a director of Artivion because of his expertise in accounting and financial reporting, particularly in the biotechnology industry. He serves as Chair of the Audit Committee and is a member of the Innovation and Healthcare Compliance Committee. Fiscal 2024 Director Compensation: $229,993.